Healthcare - Biotechnology - NASDAQ - US
$ 7.445
-7.29 %
$ 631 M
Market Cap
-14.6
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
118.98%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Anavex Life Sciences Corp.
AVXL has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart AVXL
EBIT FORECAST
EBIT Forecast Chart AVXL
NET INCOME FORECAST
Net Income Chart AVXL